| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153657 | American Heart Journal | 2005 | 5 Pages |
Abstract
Estrogen and estrogen plus medroxyprogesterone significantly raise CRP levels in women with established coronary disease. In contrast, IL-6 levels are not affected by estrogen or estrogen plus progestin. Estrogen-induced changes in CRP are not associated with progression of atherosclerosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Susan G. MD, Bridget PhD, David M. MD, MHS, FAHA,